Max Robotics — Global Service Robot Directory + US Certification

About

Memorial Sloan Kettering Cancer Center (MSK) stands as one of the world's premier cancer research and treatment institutions, with a research portfolio that sits at the intersection of oncology, surgical innovation, and minimally invasive robotic technology. For prospective collaborators and trainees, MSK offers a uniquely rigorous environment where clinical excellence drives cutting-edge scientific inquiry across virtually every cancer type and treatment modality. MSK's surgical research program has made transformative contributions to the field of robotic and minimally invasive oncologic surgery. The institution's highly cited systematic reviews and meta-analyses on robot-assisted radical prostatectomy — collectively accumulating thousands of citations — have shaped global surgical standards and informed best-practice consensus guidelines, including the landmark Pasadena Consensus Panel recommendations. MSK researchers have been equally influential in bladder cancer surgery, conducting one of the first randomized clinical trials directly comparing open and robotic radical cystectomy, a study that continues to anchor evidence-based urologic practice worldwide. Beyond urology, MSK has pioneered robotic and minimally invasive approaches in thoracic surgery, gynecologic oncology, and head and neck cancer. Notable contributions include early adoption of robotic lobectomy, transoral robotic surgery for head and neck malignancies, and the use of near-infrared fluorescence imaging for sentinel lymph node detection in uterine and cervical cancers. The institution's early work on neoadjuvant immunotherapy with nivolumab for resectable lung cancer has further positioned MSK at the forefront of combining surgical and systemic cancer treatment strategies. With a legacy stretching back decades — exemplified by landmark bladder cancer surgery data published as early as 1962 — and an ongoing commitment to evidence synthesis, clinical trials, and technological innovation, Memorial Sloan Kettering remains an unmatched destination for those seeking to advance the science and practice of surgical oncology.